Description

This case-based virtual program provided an evidence-based review of the prevalence, diagnosis, and management of mixed-phenotype ATTR amyloidosis (ATTRv), including new Canadian consensus recommendations and current therapeutic options.

Learning Objectives:

• Examine the prevalence, diagnosis, and management of mixed-phenotype ATTR amyloidosis (ATTRv), alongside newly published Canadian consensus recommendations.
• Discuss the significance of a multidisciplinary approach to managing ATTRv, involving collaboration between neurology, cardiology and primary care.
• Review current and emerging therapeutic options for ATTRv.

Faculty

• Milan Gupta, MD, FRCPC, FCCS, CPC(HC)
• Nowell Fine, MD, SM, FRCPC
• Genevieve Matte, MDCM, FRCPC
• Ahmad Masri, MD, MS

Program slides:

A copy of the program slides is available for CCRN members with a resource library subscription. View pricing and download options on the Resources tab.